Private Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.1M | Hold |
55,904
| – | – | 1.23% | 19 |
|
|
2026
Q1 | $12.2M | Hold |
55,904
| – | – | 1.39% | 18 |
|
|
2025
Q4 | $12.8M | Sell |
55,904
-449
| -0.8% | -$102K | 1.3% | 16 |
|
|
2025
Q3 | $13M | Hold |
56,353
| – | – | 1.45% | 20 |
|
|
2025
Q2 | $10.5M | Hold |
56,353
| – | – | 1.27% | 21 |
|
|
2025
Q1 | $11.8M | Hold |
56,353
| – | – | 1.41% | 21 |
|
|
2024
Q4 | $10M | Hold |
56,353
| – | – | 1.19% | 23 |
|
|
2024
Q3 | $11.1M | Sell |
56,353
-575
| -1% | -$107K | 1.22% | 25 |
|
|
2024
Q2 | $9.76M | Sell |
56,928
-2,657
| -4% | -$440K | 1.09% | 24 |
|
|
2024
Q1 | $10.8M | Sell |
59,585
-250
| -0.4% | -$43.1K | 1.35% | 22 |
|
|
2023
Q4 | $9.27M | Sell |
59,835
-9,448
| -14% | -$1.38M | 1.41% | 20 |
|
|
2023
Q3 | $9.78M | Sell |
69,283
-73
| -0.1% | -$10.7K | 1.51% | 17 |
|
|
2023
Q2 | $9.34M | Sell |
69,356
-3,655
| -5% | -$536K | 1.53% | 20 |
|
|
2023
Q1 | $11.6M | Sell |
73,011
-20,433
| -22% | -$3.12M | 2.19% | 13 |
|
|
2022
Q4 | $15.1M | Hold |
93,444
| – | – | 2.59% | 12 |
|
|
2022
Q3 | $12.5M | Sell |
93,444
-75
| -0.1% | -$10.8K | 2.17% | 15 |
|
|
2022
Q2 | $14.3M | Buy |
93,519
+25
| +0% | +$3.82K | 2.41% | 11 |
|
|
2022
Q1 | $15.2M | Sell |
93,494
-1,250
| -1% | -$182K | 2.21% | 11 |
|
|
2021
Q4 | $12.8M | Sell |
94,744
-1,167
| -1% | -$138K | 2.05% | 15 |
|
|
2021
Q3 | $10.3M | Buy |
95,911
+1,250
| +1% | +$143K | 1.72% | 19 |
|
|
2021
Q2 | $10.7M | Sell |
94,661
-526
| -0.6% | -$59.2K | 1.8% | 23 |
|
|
2021
Q1 | $10.3M | Sell |
95,187
-31,695
| -25% | -$3.39M | 1.92% | 20 |
|
|
2020
Q4 | $13.6M | Hold |
126,882
| – | – | 2.74% | 7 |
|
|
2020
Q3 | $11.1M | Buy |
126,882
+361
| +0.3% | +$34K | 2.58% | 9 |
|
|
2020
Q2 | $12.4M | Sell |
126,521
-1,000
| -0.8% | -$88K | 3.22% | 10 |
|
|
2020
Q1 | $9.72M | Buy |
127,521
+5,669
| +5% | +$483K | 3.08% | 13 |
|
|
2019
Q4 | $10.8M | Buy |
121,852
+950
| +0.8% | +$78.9K | 2.65% | 13 |
|
|
2019
Q3 | $9.15M | Buy |
120,902
+8,050
| +7% | +$552K | 2.54% | 13 |
|
|
2019
Q2 | $8.21M | Buy |
112,852
+76,892
| +214% | +$6.04M | 2.32% | 16 |
|
|
2019
Q1 | $2.9M | Sell |
35,960
-250
| -0.7% | -$20.5K | 0.88% | 32 |
|
|
2018
Q4 | $3.34M | Hold |
36,210
| – | – | 1.2% | 30 |
|
|
2018
Q3 | $3.42M | Hold |
36,210
| – | – | 0.95% | 36 |
|
|
2018
Q2 | $3.35M | Sell |
36,210
-100
| -0.3% | -$9.77K | 1.05% | 37 |
|
|
2018
Q1 | $3.44M | Hold |
36,310
| – | – | 1.14% | 33 |
|
|
2017
Q4 | $3.51M | Sell |
36,310
-5,110
| -12% | -$482K | 1.22% | 30 |
|
|
2017
Q3 | $3.68M | Sell |
41,420
-200
| -0.5% | -$15.2K | 1.26% | 29 |
|
|
2017
Q2 | $3.02M | Buy |
41,620
+145
| +0.3% | +$9.75K | 0.98% | 33 |
|
|
2017
Q1 | $2.7M | Buy |
41,475
+400
| +1% | +$25.1K | 0.88% | 33 |
|
|
2016
Q4 | $2.57M | Sell |
41,075
-25
| -0.1% | -$1.53K | 0.88% | 37 |
|
|
2016
Q3 | $2.59M | Buy |
41,100
+400
| +1% | +$25.9K | 0.92% | 36 |
|
|
2016
Q2 | $2.52M | Sell |
40,700
-360
| -0.9% | -$21.9K | 0.95% | 39 |
|
|
2016
Q1 | $2.35M | Hold |
41,060
| – | – | 1.05% | 35 |
|
|
2015
Q4 | $2.43M | Hold |
41,060
| – | – | 1.05% | 39 |
|
|
2015
Q3 | $2.23M | Buy |
41,060
+60
| +0.1% | +$3.91K | 0.93% | 42 |
|
|
2015
Q2 | $2.75M | Buy |
41,000
+200
| +0.5% | +$13.1K | 0.9% | 44 |
|
|
2015
Q1 | $2.39M | Hold |
40,800
| – | – | 0.87% | 46 |
|
|
2014
Q4 | $2.67M | Hold |
40,800
| – | – | 1.01% | 48 |
|
|
2014
Q3 | $2.36M | Hold |
40,800
| – | – | 0.76% | 54 |
|
|
2014
Q2 | $2.3M | Hold |
40,800
| – | – | 0.74% | 57 |
|
|
2014
Q1 | $2.1M | Sell |
40,800
-100
| -0.2% | -$5.05K | 0.8% | 50 |
|
|
2013
Q4 | $2.16M | Sell |
40,900
-100
| -0.2% | -$4.92K | 0.74% | 51 |
|
|
2013
Q3 | $1.83M | Sell |
41,000
-50
| -0.1% | -$2.22K | 0.67% | 54 |
|
|
2013
Q2 | $1.7M | Buy |
+41,050
| New | +$1.8M | 0.63% | 59 |
|
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Private Capital Advisors's ABBV Position: Q2 2026 in Review
Private Capital Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 55,904 shares worth $14.1M. The position accounts for 1.23% of the portfolio, ranked #19.
Private Capital Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.2M in Q1 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Private Capital Advisors held 55,904 shares of AbbVie worth $14.1M as of Q2 2026.
- Private Capital Advisors left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 1.23% of Private Capital Advisors's portfolio in Q2 2026, its #19 holding.
- Private Capital Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Private Capital Advisors's AbbVie position peaked at $15.2M in Q1 2022.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.